ENTITY
Astellas Pharma

Astellas Pharma (4503 JT)

9
Analysis
Health Care • Japan
Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of urology, immunology including transplantation and infectious diseases, oncology, euroscience and DM complications and metabolic diseases. The Company researches, develops, manufactures, and promotes its prescription drugs through subsidiaries in the US, Europe, and Asia.
more
bullish•MSCI ACWI Index
•07 Sep 2018 20:32

Bottoms-Up View on Developed Markets: Actionable Stocks, Part 2

Our outlook remains neutral for global ex-U.S. markets while horizontal consolidation continues on the MSCI ACWI ex-U.S. index.  In today’s report...

Logo
559 Views
Share
bullish•MSCI ACWI Index
•17 Aug 2018 23:22

Global Strategy: Carnage Continuation Amid Turkey Turmoil and US Dollar Breakout

Corrections across global ex-US markets continue to limit attractive investment opportunities from both a price and relative strength perspective. ...

Logo
601 Views
Share
•29 Jul 2018 18:01

Japan Fortnightly Update: Banks to Neutral/Utilities to Negative - Results Momentum Still Slowing

CYCLICAL SECTORS RALLY WITH THE MARKET - Japanese equities have rallied 3.6% over the last two weeks, and the market composite is now flat since...

Logo
491 Views
Share
bullish•MSCI World Index
•24 Jul 2018 04:25

Global Equity Strategy: Where to Hide Outside the U.S.

The U.S. has continued to separate itself from broad emerging market and developed international indexes. One positive is that MSCI EM and MSCI...

Logo
618 Views
Share
bearish•Fast Retailing
•23 Jul 2018 07:38

JAPAN PASSIVE:  The Nikkei 225 Baskets if BOJ Changes

Last week in JAPAN PASSIVE:  BOJ Heading For Trouble with Nikkei 225 I discussed the BOJ's past and current ETF purchasing selection, ownership,...

Logo
726 Views
Share
x